Drugs / CSL Trivalent Inactivated Influenza Vaccine - Thimerosal-free
last change Aug 2006 re-read 3 minutes ago

CSL Trivalent Inactivated Influenza Vaccine - Thimerosal-free

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00333398 Jun → Aug 2006 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CSL Trivalent Inactivated Influenza Vaccine - Thimerosal-free ClinicalTrials.gov intervention name — accepted as the source's own label NCT00333398 ↗
Modality Vaccine “influenza vaccine” NCT00333398 ↗